What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Wei Zheng spends much of his time researching Internal medicine, Breast cancer, Odds ratio, Cancer and Genome-wide association study.
The various areas that Wei Zheng examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology.
His Breast cancer study deals with Gynecology intersecting with Obstetrics and Menopause.
His biological study spans a wide range of topics, including Body mass index, Case-control study, Pancreatic cancer and Risk factor.
His Cancer research is multidisciplinary, relying on both Pathology and Hazard ratio.
His Genome-wide association study study combines topics in areas such as Genetic association, Bioinformatics and Genetic predisposition.
His most cited work include:
- Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults (2180 citations)
- Sloan digital sky survey: Early data release (2156 citations)
- Sloan Digital Sky Survey: Early data release (2084 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Breast cancer, Cancer, Oncology and Odds ratio.
As a part of the same scientific family, Wei Zheng mostly works in the field of Internal medicine, focusing on Endocrinology and, on occasion, Physiology.
His Breast cancer research includes themes of Single-nucleotide polymorphism, Genome-wide association study, Genotype and Gynecology.
His biological study spans a wide range of topics, including Lung cancer, Risk factor and Pathology.
In his work, Obesity is strongly intertwined with Body mass index, which is a subfield of Odds ratio.
His work deals with themes such as Relative risk, Epidemiology, Cohort study and Hazard ratio, which intersect with Prospective cohort study.
He most often published in these fields:
- Internal medicine (43.67%)
- Breast cancer (22.50%)
- Cancer (21.74%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (43.67%)
- Oncology (18.41%)
- Breast cancer (22.50%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Oncology, Breast cancer, Genome-wide association study and Cancer are his primary areas of study.
His work in Confidence interval, Odds ratio, Hazard ratio, Cohort study and Meta-analysis are all subfields of Internal medicine research.
His Odds ratio research incorporates elements of Logistic regression and Case-control study.
His Cohort study research is multidisciplinary, incorporating perspectives in Lung cancer, Demography and Prospective cohort study.
His Oncology research includes elements of Mendelian randomization, Ovarian cancer, Genotype, Colorectal cancer and Prostate cancer.
The concepts of his Genome-wide association study study are interwoven with issues in Transcriptome, Genetic association and Genetic predisposition.
Between 2018 and 2021, his most popular works were:
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (257 citations)
- Discovery of common and rare genetic risk variants for colorectal cancer (131 citations)
- Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence (122 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His primary scientific interests are in Internal medicine, Genome-wide association study, Oncology, Breast cancer and Prospective cohort study.
His research investigates the link between Internal medicine and topics such as Mendelian randomization that cross with problems in Mendelian Randomization Analysis.
His Genome-wide association study study combines topics from a wide range of disciplines, such as Colorectal cancer, Case-control study and Genetic association.
His Oncology research is multidisciplinary, relying on both Ovarian cancer, Prostate cancer and Genetic predisposition.
Wei Zheng has researched Breast cancer in several fields, including Cancer research, Epidemiology and Risk factor.
His Prospective cohort study study combines topics in areas such as Body mass index, Obesity, Demography, Lung cancer and Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
